728 related articles for article (PubMed ID: 18718565)
1. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
[TBL] [Abstract][Full Text] [Related]
2. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
3. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
4. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys.
Tanaka M; Mori H; Kawabata K; Mashiba T
Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564
[TBL] [Abstract][Full Text] [Related]
5. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
6. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
Fox J; Miller MA; Newman MK; Turner CH; Recker RR; Smith SY
J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
[TBL] [Abstract][Full Text] [Related]
7. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate.
Itoh F; Kojima M; Furihata-Komatsu H; Aoyagi S; Kusama H; Komatsu H; Nakamura T
J Bone Miner Res; 2002 Mar; 17(3):534-43. PubMed ID: 11874245
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats.
Tamura Y; Miyakoshi N; Itoi E; Abe T; Kudo T; Tsuchida T; Kasukawa Y; Sato K
J Bone Miner Res; 2001 Mar; 16(3):541-9. PubMed ID: 11277272
[TBL] [Abstract][Full Text] [Related]
9. Responses of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariohysterectomized beagles with calcium restriction.
Yoshida Y; Moriya A; Kitamura K; Inazu M; Okimoto N; Okazaki Y; Nakamura T
J Bone Miner Res; 1998 Jun; 13(6):1011-22. PubMed ID: 9626633
[TBL] [Abstract][Full Text] [Related]
10. Effects of eight-month treatment with ONO-5334, a cathepsin K inhibitor, on bone metabolism, strength and microstructure in ovariectomized cynomolgus monkeys.
Ochi Y; Yamada H; Mori H; Nakanishi Y; Nishikawa S; Kayasuga R; Kawada N; Kunishige A; Hashimoto Y; Tanaka M; Sugitani M; Kawabata K
Bone; 2014 Aug; 65():1-8. PubMed ID: 24784023
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
[TBL] [Abstract][Full Text] [Related]
12. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
Bone; 2016 May; 86():43-52. PubMed ID: 26921823
[TBL] [Abstract][Full Text] [Related]
13. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.
Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T
Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990
[TBL] [Abstract][Full Text] [Related]
14. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
[TBL] [Abstract][Full Text] [Related]
15. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
16. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
17. Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats.
Zhang R; Liu ZG; Li C; Hu SJ; Liu L; Wang JP; Mei QB
Bone; 2009 Sep; 45(3):553-9. PubMed ID: 18835589
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
[TBL] [Abstract][Full Text] [Related]
19. Effects of lasofoxifene on bone in surgically postmenopausal cynomolgus monkeys.
Lees C; Shen V; Brommage R
Menopause; 2007; 14(1):97-105. PubMed ID: 17075430
[TBL] [Abstract][Full Text] [Related]
20. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
